Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Credihealth, Rubique tie-up to introduce collateral-free medical loan facility

      Credihealth, Rubique tie-up to introduce collateral-free medical loan facility

      Ruby Khatun Khatun12 July 2017 9:58 AM IST
      New Delhi: Medical assistance company Credihealth on Tuesday announced the launch of a medical loan facility on its platform.The company announced its...
      Maha Hospitals reused catheters, charged patients 77 percent of MRP: Maharastra FDA

      Maha Hospitals reused catheters, charged patients 77 percent of MRP: Maharastra FDA

      Ruby Khatun Khatun12 July 2017 9:55 AM IST
      Mumbai: Recent reports given by the Maharashtra FDA point out that 8 private hospitals in Maharashtra have indulged in an unethical practice by...
      Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

      Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

      Ruby Khatun Khatun12 July 2017 9:46 AM IST
      DUBLIN: Medtronic plc announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM)...
      Suven Life Sciences gets NCEs patents from Israel, Macau and S Korea

      Suven Life Sciences gets NCEs patents from Israel, Macau and S Korea

      Ruby Khatun Khatun11 July 2017 2:22 PM IST
      New Delhi: Suven Life Sciences has received product patents from Israel, Macau and South Korea for New Chemical Entities (NCEs) used in the treatment...
      USFDA to lift import alert on Visakhapatnam unit: Divis Labs

      USFDA to lift import alert on Visakhapatnam unit: Divis Labs

      Ruby Khatun Khatun11 July 2017 10:09 AM IST
      New Delhi: Drug firm Divis Laboratories said US health regulator will lift an import alert imposed on the company's Unit-II at Visakhapatnam.The...
      Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

      Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

      Ruby Khatun Khatun11 July 2017 10:09 AM IST
      Vadodara: Alembic Pharmaceuticals Limited announced that the company has received tentative approval from the US Food & Drug Administration...
      Sanofi to buy vaccines biotech group Protein Sciences

      Sanofi to buy vaccines biotech group Protein Sciences

      Ruby Khatun Khatun11 July 2017 9:46 AM IST
      French drugmaker and healthcare group Sanofi is to buy privately-held U.S vaccines biotech company Protein Sciences for an initial amount of $650...
      NPPA revises Guidelines regarding discontinuation of scheduled formulations

      NPPA revises Guidelines regarding discontinuation of scheduled formulations

      Ruby Khatun Khatun11 July 2017 9:12 AM IST
      Authority to examine discontinuation of medical devices on case-to-case basisThrough an recent office memorandum, Government of India, Ministry of...
      Lupin gets USFDA nod to market anti-fungal capsules

      Lupin gets USFDA nod to market anti-fungal capsules

      Ruby Khatun Khatun11 July 2017 9:09 AM IST
      New Delhi: Drug firm Lupin has received nod from the US health regulator to market its Flucytosine capsules used for treatment of fungal...
      Lupin sets off down Indian pharmas long road to redemption

      Lupin sets off down Indian pharma's long road to redemption

      Ruby Khatun Khatun10 July 2017 4:06 PM IST
      GOA: In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier.Most of the last six months on his desk calendar is marked...
      GSK Pharma to invest Rs 1000 crore in Karnataka plant

      GSK Pharma to invest Rs 1000 crore in Karnataka plant

      Ruby Khatun Khatun10 July 2017 4:00 PM IST
      Mumbai: Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd (GSK) is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit...
      Zydus Cadila gets USFDA nod to market Doxazosin tablets

      Zydus Cadila gets USFDA nod to market Doxazosin tablets

      Ruby Khatun Khatun10 July 2017 12:15 PM IST
      New Delhi: Zydus Cadila has received approval from the US health regulator to market Doxazosin tablets, used for treatment of high blood pressure and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok